EUCTR2011-005968-24-IT进行中（未招募）不适用
A multicenter, randomized, double-blind, placebo-controlled Phase IIb Efficacy Study of Vx-001, a peptide-based cancer vaccine aimed to maintain disease control after first line treatment in HLA-A*0201 positive patients with TERT positive NSCLC (stage IV or recurrent stage I-III) - VaxLung
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- MF from 18 years of age; - Documented stage IV NSCLC or recurrent stage I-III disease; - Patients treated with 4 cycles platinum based 1st line chemotherapy; - Documented HLA-A*0201 positive; - TERT-positive NSCLC.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Mixed small cell and NSCLC histologies; - Patients with stage IV or recurrent NSCLC who have been previously treated with therapy other than platinum-based first-line chemotherapy; - Prior treatment with cancer vaccines; - Prior treatment with immunotherapy within four weeks prior to randomization.
研究者
相似试验
撤回
3 期
A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclerosis.Disease of nerve cells that control musclesNeurodegenerative syndrome10029317NL-OMON54862Ferrer Internacional, S.A.10
尚未招募
4 期
A multicenter, randomized, double-blind, placebo-controlled exploratory clinical trial for efficacy and safety of Simo Decoction in the treatment of functional constipation (qi stagnation)Functional constipation (air stagnation)ITMCTR2200005597Xiyuan Hospital, China Academy of Chinese Medical Sciences
进行中（未招募）
1 期
A Phase 3 study of efficacy and safety of remibrutinib in the treatment of chronic spontaneous urticaria in adults inadequately controlled by H1-antihistaminesChronic Spontaneous UrticariaMedDRA version: 20.0Level: PTClassification code 10072757Term: Chronic spontaneous urticariaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2021-000471-37-ESovartis Farmacéutica S.A.450
尚未招募
3 期
A multicenter, randomized, double-blind, placebo-controlled study of enzastaurin for the prevention of arterial events in patients with vascular Ehlers-Danlos Syndrome (vEDS) confirmed with COL3A1 mutations, followed by an open label extension (OLE)NL-OMON51515Aytu BioPharma, Inc50
尚未招募
1 期
A multicenter, randomized, double-blind, placebo-controlled clinical trial of Reduning injection in the treatment of viral pneumoniaITMCTR2100005197The First Affiliated Hospital Of Guangzhou Medical University All Rights Reserved